Overexpression of AXL is associated with several aspects of cancer such as proliferation, epithelial–mesenchymal transition (EMT), invasion, and resistance to drug treatment (Antony et al., 2016; Goruppi et al., 1997; Hafizi and Dahlback, 2006; Sainaghi et al., 2005). The gene discussed is AXL; the disease is cancer.